New peptide research could alter sperm motility and impact on male fertility
A new form of male contraception and enhanced fertility treatments could both soon be a reality thanks to pioneering work from two University of Wolverhampton scientists. Professor John Howl and Dr Sarah Jones are at the forefront of cell penetrating peptide research which it is hoped could be used in both IVF and birth control techniques in the future. They have teamed up with the University of Aveiro in Portugal on a €194,000 three-year project to look at the impact of cell penetrating peptides – and in particular the way in which they can control the function of sperm.